High Cholesterol & Cardiovascular Risk Assessment in Toronto
Evidence-informed naturopathic care focused on advanced lipid testing, metabolic health, and long-term cardiovascular prevention
“Cardiovascular risk is rarely just a number on a page. I find it far more useful to sit with a patient’s full lab picture – cholesterol, ApoB, Lp(a), insulin levels, inflammatory markers – alongside their family history and lifestyle, and really explain what it means for them specifically. Most patients leave that conversation with a clearer picture of their risk than they’ve ever had – and a concrete plan that doesn’t start and end with ‘take a statin.'”
– Dr. Makoto Trotter, ND
In reality, cardiovascular risk is often far more nuanced.
Standard cholesterol panels may miss important patterns related to inflammation, insulin resistance, metabolic health, genetics, thyroid function, liver health, and advanced cardiovascular risk markers such as ApoB and Lipoprotein(a) [Lp(a)].
With over 20 years of clinical experience, Dr. Makoto Trotter provides comprehensive cardiovascular and metabolic assessment focused on identifying the factors that may actually be contributing to elevated cardiovascular risk, while helping patients better understand what their lab results truly mean.
Many patients seek care not only for elevated cholesterol numbers, but because they want a more in-depth interpretation of their blood work, clearer guidance regarding long-term prevention, and a more comprehensive understanding of their overall cardiovascular health.
Discuss your cholesterol results, cardiovascular concerns, or advanced testing questions with Dr. Makoto Trotter to determine whether a comprehensive cardiovascular assessment may be appropriate.
Book a free 15-minute discovery call to discuss your concerns and next steps.
An elevated LDL cholesterol level does not always tell the full story.
Cardiovascular risk assessment should consider multiple factors together, including:
In some individuals, cholesterol elevation may be mild and relatively low risk.
In others, more advanced testing may reveal a significantly increased cardiovascular risk profile despite “normal” standard cholesterol values.
The goal is not simply to chase cholesterol numbers, but to better understand the overall cardiovascular picture and identify the factors most relevant to long-term health and prevention.
Depending on the individual case, additional assessment may include:
Care is individualized based on symptoms, history, family risk factors, current medications, lifestyle factors, and laboratory findings.
High cholesterol can sometimes be influenced by underlying contributors such as:
Addressing these underlying factors may help support healthier long-term cardiovascular outcomes beyond simply lowering cholesterol values alone.
Recommendations are individualized and based on the overall clinical picture, laboratory findings, cardiovascular risk profile, and patient goals.
Dr. Makoto Trotter provides evidence-informed cardiovascular and metabolic assessment focused on understanding the bigger picture behind elevated cholesterol and long-term cardiovascular health.
Whether you have elevated LDL, ApoB, triglycerides, concerns regarding Lp(a), a family history of cardiovascular disease, or simply want a more proactive understanding of your lab work, individualized assessment may help clarify the next steps.
Patients from across Toronto seek care for advanced cholesterol interpretation, cardiovascular prevention, metabolic health assessment, and evidence-informed lifestyle support.
Book a free 15-minute discovery call to discuss your symptoms and next steps.
A major part of cardiovascular assessment involves carefully reviewing laboratory patterns within the broader context of the individual patient.
Many patients have already completed blood work through their physician but are left with unanswered questions such as:
A detailed review of laboratory findings may help identify meaningful patterns that are not always obvious from a standard cholesterol panel alone.
This includes evaluating cardiovascular risk in the context of:
Recommendations are individualized and may include support related to:
Care focuses on realistic, sustainable strategies tailored to the individual rather than one-size-fits-all protocols.
For some individuals, medication may still play an important role in cardiovascular risk reduction.
Naturopathic care can also help support:
Recommendations are based on the overall clinical picture and individualized cardiovascular risk assessment.
When appropriate, patients may also be encouraged to follow up with their primary care provider or seek further medical evaluation for ongoing cardiovascular management.
This type of assessment may be helpful for individuals who:
No. Cardiovascular risk is influenced by many factors including inflammation, blood sugar regulation, insulin resistance, blood pressure, genetics, smoking history, metabolic health, sleep, stress, and lifestyle patterns.
ApoB is a marker that reflects the number of potentially atherogenic lipoprotein particles in circulation. In some cases, it may provide additional cardiovascular risk information beyond standard LDL cholesterol alone.
LDL cholesterol measures the total amount of cholesterol carried in LDL particles. ApoB measures the actual number of those particles – and particle number is increasingly recognized as a more accurate predictor of cardiovascular risk than cholesterol content alone. Two patients can have identical LDL cholesterol levels but very different particle numbers, and therefore very different risk profiles. This is one reason why standard LDL alone can miss important cardiovascular risk patterns.
Lipoprotein(a), often written as Lp(a), is a genetically influenced cardiovascular risk marker that is not typically included on a standard cholesterol panel. Elevated Lp(a) levels may increase cardiovascular risk in certain individuals, particularly when combined with other factors such as elevated ApoB, inflammation, insulin resistance, or family history of cardiovascular disease.
Yes. Existing laboratory results can often provide valuable insight and may help determine whether additional testing or further evaluation would be appropriate.
Not necessarily. Treatment decisions depend on the overall cardiovascular risk profile, laboratory findings, family history, medical history, and individual clinical context.
Elevated triglycerides and dyslipidemia are closely linked to fatty liver disease – both conditions share the same metabolic root causes and are frequently treated together.
Yes – significantly. Nutrition, exercise, sleep quality, stress, insulin resistance, and body composition all directly influence cardiovascular risk markers. In many cases addressing these factors produces meaningful improvements in ApoB, triglycerides, inflammation, and metabolic health – sometimes more effectively than medication for certain risk profiles. Recommendations are always individualized based on the full clinical picture.
The phrase “sometimes more effectively than medication for certain risk profiles” is the key addition – it’s accurate, evidence-supported, and directly speaks to the patient who is weighing natural approaches against a statin prescription.
Recommendations are individualized and based on current laboratory findings, clinical history, symptoms, risk factors, and overall health status. This page is intended for educational purposes only and should not replace individualized medical advice or emergency medical care.
Discuss your cholesterol results, cardiovascular concerns, or advanced testing questions with Dr. Makoto Trotter and explore whether a more comprehensive cardiovascular assessment may be appropriate.
👉 Book your initial consultation to get a clear plan forward.